Tenderwize
Retour à la recherche

Non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07) under an open-house model

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Expired · Sep 30, 2026·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Eisen(III)natrium-Gluconat-Komplex (B03AC07) im Rahmen eines sogenannten Open-House-Modells.

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

The buyer reserves the right to replace open-house contracts with exclusive discount contracts during the term, leading...

No estimated value, volume, or pricing information is provided; potential revenue is unknown.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Sep 30, 2026

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Conclusion of non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07)
  • Contracts are open to all pharmaceutical companies with authorized and marketable products in Germany
Afficher le résumé complet

Open-house model for non-exclusive discount contracts for pharmaceutical products with active substance iron(III) sodium gluconate complex (B03AC07). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform, non-negotiable discount contracts on a first-come, first-served basis. Contracts run for a maximum of 24 months from December 2024. The notice is published for transparency and is not a standard public procurement procedure.

Risques

The buyer reserves the right to replace open-house contracts with exclusive discount contracts during the term, leading...

No estimated value, volume, or pricing information is provided; potential revenue is unknown.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Proof of marketability via listing in Lauer-Taxe or AMIce database

Eligibility

  • Only drugs that are authorized and marketable in Germany are eligible

Administrative

  • Submission of signed contract documents and required annexes by specified deadlines

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No explicit award criteria; all eligible applicants are accepted.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0000

Non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07) under an open-house model

Non-exclusive discount contracts for the active substance B03AC07. All interested pharmaceutical companies with authorized and marketable drugs in Germany can join. Uniform terms, no individual negotiations. Contracts can start monthly from December 2024 until November 2026.

SuppliesEU fundedElectronic submission

Localisation

DEB3D, Germany

Durée

Nov 2024 - Nov 2026

Catégorie

Pharmaceutical products

Critères d'attribution

No explicit award criteria; all eligible applicants are accepted.

Date limite

Expired Sep 30, 2026

Détails de la procédure

Date de publication
10 Oct 2024
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
615563-2024

Documents (1)

Appels d'offres similaires